Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
McKinsey
Colorcon
Novartis
Accenture
Moodys
Chubb
Argus Health
Daiichi Sankyo
Baxter

Generated: January 18, 2018

DrugPatentWatch Database Preview

Glenmark Generics Company Profile

« Back to Dashboard

What is the competitive landscape for GLENMARK GENERICS, and what generic and branded alternatives to GLENMARK GENERICS drugs are available?

GLENMARK GENERICS has sixty-eight approved drugs.

There are three tentative approvals on GLENMARK GENERICS drugs.

Summary for Glenmark Generics
US Patents:0
Tradenames:59
Ingredients:54
NDAs:68

Drugs and US Patents for Glenmark Generics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics URSODIOL ursodiol TABLET;ORAL 090801-001 Jul 12, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics LEVOFLOXACIN levofloxacin TABLET;ORAL 200250-003 Jun 20, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 077987-004 Dec 28, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 201967-002 Dec 31, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics THEOPHYLLINE theophylline TABLET, EXTENDED RELEASE;ORAL 090355-002 Jul 13, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics TOPIRAMATE topiramate TABLET;ORAL 077627-001 Mar 27, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics NILSTAT nystatin SUSPENSION;ORAL 050299-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 090135-005 Feb 25, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics MELOXICAM meloxicam TABLET;ORAL 077932-001 Jul 19, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics LEVOFLOXACIN levofloxacin TABLET;ORAL 200250-002 Jun 20, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for GLENMARK GENERICS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 6/3/2015
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Fuji
Argus Health
US Army
Baxter
QuintilesIMS
US Department of Justice
Novartis
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot